| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.45▼ | 1.42▲ | 1.41▲ | 1.39▲ | 1.40▲ |
| MA10 | 1.43▲ | 1.40▲ | 1.40▲ | 1.39▲ | 1.46▼ |
| MA20 | 1.41▲ | 1.39▲ | 1.40▲ | 1.39▲ | 1.60▼ |
| MA50 | 1.39▲ | 1.39▲ | 1.39▲ | 1.43▲ | 1.92▼ |
| MA100 | 1.39▲ | 1.40▲ | 1.39▲ | 1.69▼ | 3.36▼ |
| MA200 | 1.40▲ | 1.39▲ | 1.44▲ | 1.85▼ | 8.62▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.008▲ | 0.006▲ | 0.008▲ | 0.005▲ |
| RSI | 65.104▲ | 62.872▲ | 60.075▲ | 52.356▲ | 43.046▼ |
| STOCH | 83.485▲ | 81.328▲ | 61.203 | 43.139 | 38.690 |
| WILL %R | -21.429▲ | -14.286▲ | -14.286▲ | -31.250 | -57.143 |
| CCI | 50.246 | 128.819▲ | 167.935▲ | 116.331▲ | -33.520 |
|
Sunday, January 18, 2026 07:14 AM
Soligenix (NASDAQ: SNGX) is a New Jersey-based biopharmaceutical company focused on developing products to treat rare diseases where there is an unmet medical need. The company recently received ...
|
|
Wednesday, December 17, 2025 05:23 AM
Soligenix, Inc. (NASDAQ: SNGX) on Wednesday announced extended results of its ongoing Phase 2a trial of SGX302 (synthetic hypericin) for mild-to-moderate psoriasis. In this extension (Cohort 3) of the ...
|
|
Wednesday, December 10, 2025 12:29 AM
AUSTIN, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled ““Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/01/26 | 1.445 | 1.455 | 1.44 | 1.44 | 144,789 |
| 21/01/26 | 1.38 | 1.43 | 1.35 | 1.40 | 235,100 |
| 20/01/26 | 1.40 | 1.41 | 1.35 | 1.38 | 146,400 |
| 16/01/26 | 1.43 | 1.43 | 1.34 | 1.41 | 140,414 |
| 15/01/26 | 1.40 | 1.40 | 1.33 | 1.34 | 202,186 |
| 14/01/26 | 1.38 | 1.4185 | 1.34 | 1.38 | 315,529 |
| 13/01/26 | 1.38 | 1.4047 | 1.36 | 1.37 | 72,028 |
| 12/01/26 | 1.38 | 1.39 | 1.33 | 1.37 | 152,975 |
| 09/01/26 | 1.43 | 1.44 | 1.345 | 1.35 | 141,930 |
| 08/01/26 | 1.48 | 1.48 | 1.41 | 1.44 | 192,656 |
|
|
||||
|
|
||||
|
|